We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Graphene-Based Transistor Detects Bacteria in Microdroplets

By LabMedica International staff writers
Posted on 01 Jul 2019
Print article
Image: An illustration of a bacterial detection by the G-FET device (Photo courtesy of Osaka University).
Image: An illustration of a bacterial detection by the G-FET device (Photo courtesy of Osaka University).
A team of Japanese researchers developed a graphene-based field-effect transistor and used it to detect the gastric cancer pathogen Helicobacter pylori in fluid microdroplets.

Graphene is an allotrope of carbon in the form of a two-dimensional hexagonal lattice in which one atom forms each vertex. It is the basic structural element of other allotropes, including graphite, charcoal, carbon nanotubes, and fullerenes. At one atom thick, graphene is the thinnest material known to man and is also one of the strongest, being approximately 200 times stronger than steel. It is an excellent conductor of heat and electricity and has interesting light absorption properties.

Investigators at Osaka University (Japan) coated micro sized sheets of graphene with specific antibodies to create highly sensitive graphene-based field effect transistors (GFETs) for use as biosensors and chemical sensors. Due to the two-dimensional structure of graphene, along with its physical properties, GFETs offer increased sensitivity, and reduced instances of false positives responses in sensing applications.

To use a GFET to detect bacteria, the investigators faced a peculiar physical limitation. The measurable range from the graphene surface is highly restricted by Debye screening, with characteristic length less than one nanometer at physiological ionic strength. This screening effect prevented the graphene sheet from being affected by binding of bacteria to the antibody coating.

To overcome the Debye screening limitation, the investigators introduced a way to monitor chemical reactions generated by the bacteria in the presence of reagents added by microfluidics to a droplet of liquid. The low molecular weight chemicals produced in the reactions were able to penetrate the Debye screen and reach the graphene surface. Electrical signals built up on the graphene surface due to these reactions were used to calculate the number of bacteria in the droplet.

The investigators demonstrated that they could achieve quantitative measurements of a target based on the site-binding model and real-time measurement of enzyme kinetics in femtoliter (10 x -15 liter or a cubic microliter) microdroplets.

The combination of a G-FET and microfluidics, called by the investigators a “lab-on-a-graphene-FET”, detected the enzyme urease with high sensitivity in the zeptomole (one 10 x -21th part of a mole, or about 600 molecules) range in 100 millimolar sodium phosphate buffer. Furthermore, the lab-on-a-graphene-FET detected the gastric cancer pathogen Helicobacter pylori captured at a distance greater than the Debye screening length from the G-FET.

"Our biosensor is essentially a mini laboratory on a graphene FET. This sensor demonstrates how two-dimensional materials such as graphene are getting closer to being applied in practical medical and healthcare applications," said first author Dr. Takao Ono, an assistant professor in the institute of scientific and industrial research at Osaka University.

The use of the G-FET device to detect H. pylori was described in the June 12, 2019, issue of the journal ACS Nano Letters.

Related Links:
Osaka University

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.